Q4 2024
Released Mar 31, 2025, during market hours
10-K filed Apr 1, 2025, 91 days after period end · 0000868278-25-000003
Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$1.49M$1.49M derivedno prior Q4 2023 on file+5.5% vs Q3 2024
Net Income-$34.36M-$34.36M derivedN/M vs Q4 2023N/M vs Q3 2024
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived-$150,000N/M
Operating Incomederived-$17,290,000N/M
Operating Cash Flowderived-$3,518,000N/M
Free Cash Flowderived-$3,558,000N/M
Margins · derived
Gross margin-10.0%
Operating margin-1157.3%
Net margin-2299.8%
What the release said
The release
Same quarter
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Revenue | $1.49M | — | $21.82M | $45.16M |
| Net Income | -$34.36M | -$8.75M | -$2.45M | $10.59M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR